Pamela Garzone currently serves as Chief Development Officer of Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, where she oversees Anixa’s vaccine and therapeutic development programs. Prior to that, Pamela was most recently the Chief Medical Officer of Calibr, a division of Scripps Research. Prior to joining Calibr, Pamela spent ten years at Pfizer (2009-2019), located in South San Francisco, CA. Before Pfizer, Pamela was Senior Director of Clinical Development at Elan Pharmaceuticals (2006-2009), focusing on early stage assets in neurodegenerative and autoimmune diseases. Prior to Elan, Pamela provided consulting services to countless executives in the area of drug development for over a decade. In the early years of her industrial career, Pamela created her pathway to leadership- managing preclinical groups such as toxicology and pharmacokinetic and drug metabolism functions in addition to planning and developing protocols for clinical pharmacology studies. Pamela has taught undergraduate and graduate students , providing courses in clinical research, experimental design and clinical pharmacology, while a faculty member of the School of Pharmacy at the University of Pittsburgh. She received the Pittsburgh School of Pharmacy Distinguished Alumni Award in 2019.

Pamela is a respected pharmaceutical executive with a significant record of achievement in drug development and leadership, ascending to the level of Chief Medical Officer. She has led teams successfully through the regulatory process, culminating in clearance of multiple INDs in different therapeutic areas and approval of registration dossiers. Pamela is valued as an authentic leader, providing inspiration and motivation, mediating conflict resolution and was chief influencer of executive management. She has interacted with health authorities (US, CHMP, PMDA, HC) for pre-IND meetings, EOP2 meetings, FDA advisory committees, and EMEA scientific advice meetings. Pamela is an invited speaker at international meetings and for prominent organizations as well as an author of peer reviewed scientific articles. Recognized for her strategic, scientific and regulatory leadership in drug development, she serves as advisor to executives of start-up and clinical stage biotechnology companies, venture capitalists and non-profit research foundations and as the co-chair of AIM-HI Women’s Venture Competition. She has extensive experience helping boards and committees achieve aggressive goals and fulfill key objectives.

Pamela has comprehensive experience providing trusted leadership on boards and committees for a variety of organizations. She has achieved outstanding achievements as National Sponsorship Chair of Women in BioScience. Additionally, she has been profiled in Clinical Leader and served as a member of its Advisory Board. She has volunteered for numerous professional and community organizations.

Pamela earned a Ph.D. in Clinical Science and M.Sc. in Pharmacy from the University of Pittsburgh and a B.Sc. in Pharmacy from Purdue University. She also obtained 2 certificates from Harvard University- the first one in Special Studies Administration and Management and Women on Boards from Harvard University. In addition, she received a certificate in Non-Profit Board Governance from College of San Mateo in California.

Pamela is married with one child. She enjoys scuba diving, hiking, running, cycling and travelling around the world.